NCT06815198 Pulsed Eco Doppler for Polmonal Discharge Velocity
| NCT ID | NCT06815198 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | LUNG |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-05-06 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2021-05-06 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chest ultrasound is increasingly being used in the diagnosis and management of the respiratory patient. With ultrasound, ultrasound artifacts representing the lung during inspiration and during exhalation are visualized and analyzed. During inspiration, the lung inflates with air while when exhaling, the lung empties. These two phases are visualized on ultrasound with a sliding motion of the pleural line, which represents the margin of the lung. The aim of the study is to identify the speed of filling and emptying of the lung by studying the characteristics of the pulsed Doppler wave to measure the speed of lung sliding as the significance of this finding has not yet been clarified. In both healthy subjects and patients with lung disease, it is not known whether there is a correlation between velocity measured by the Doppler wave with the main data recorded by a mechanical ventilator or spirometer.
Eligibility Criteria
Inclusion Criteria: * Age \>= 18 years * Acquisition of Informed Consent Exclusion Criteria: * Patients admitted to undergo major thoracic surgery. * Remote pathological history positive for recurrent PNX (≥ 2), pleural thalking or pleurodesis * Patients presenting with absolute and relative contraindications to spirometry for1 and 2a patients ie: recent myocardial infarction (within the past 3 months) or unstable angina hemoptysis thoracic aortic aneurysm
Contact & Investigator
Tommaso Tonetti, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Anestesiologia e Terapia Intensiva Polivalente
Frequently Asked Questions
Who can join the NCT06815198 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying LUNG. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06815198 currently recruiting?
Yes, NCT06815198 is actively recruiting participants. Contact the research team at tommaso.tonetti@unibo.it for enrollment information.
Where is the NCT06815198 trial being conducted?
This trial is being conducted at Bologna, Italy, Bologna, Italy.
Who is sponsoring the NCT06815198 clinical trial?
NCT06815198 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Tommaso Tonetti, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna - Anestesiologia e Terapia Intensiva Polivalente. The trial plans to enroll 100 participants.